Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.
Moll G, Jitschin R, von Bahr L, Rasmusson-Duprez I, Sundberg B, Lönnies L, Elgue G, Nilsson-Ekdahl K, Mougiakakos D, Lambris JD, Ringdén O, Le Blanc K, Nilsson B. Moll G, et al. Among authors: von bahr l. PLoS One. 2011;6(7):e21703. doi: 10.1371/journal.pone.0021703. Epub 2011 Jul 1. PLoS One. 2011. PMID: 21747949 Free PMC article.
Are therapeutic human mesenchymal stromal cells compatible with human blood?
Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, Hamad OA, Lönnies H, Magnusson PU, Sanchez J, Teramura Y, Nilsson-Ekdahl K, Ringdén O, Korsgren O, Nilsson B, Le Blanc K. Moll G, et al. Among authors: von bahr l. Stem Cells. 2012 Jul;30(7):1565-74. doi: 10.1002/stem.1111. Stem Cells. 2012. PMID: 22522999 Free article.
Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?
Moll G, Hult A, von Bahr L, Alm JJ, Heldring N, Hamad OA, Stenbeck-Funke L, Larsson S, Teramura Y, Roelofs H, Nilsson B, Fibbe WE, Olsson ML, Le Blanc K. Moll G, et al. Among authors: von bahr l. PLoS One. 2014 Jan 13;9(1):e85040. doi: 10.1371/journal.pone.0085040. eCollection 2014. PLoS One. 2014. PMID: 24454787 Free PMC article.
Enhanced oral healing following local mesenchymal stromal cell therapy.
Garming-Legert K, Tour G, Sugars R, von Bahr L, Davies LC, Le Blanc K. Garming-Legert K, et al. Among authors: von bahr l. Oral Oncol. 2015 Dec;51(12):e97-9. doi: 10.1016/j.oraloncology.2015.09.008. Epub 2015 Oct 5. Oral Oncol. 2015. PMID: 26428076 No abstract available.
13 results